Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distribution channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2024-2032

Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distribution channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A1219
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Global Specialty Generics Market: Introduction
5   Why are Specialty Generics So Lucrative?
6   Global Specialty Generics Market

    6.1    Market Overview
    6.2    Market Performance
    6.3    Impact of COVID-19
    6.4    Market Breakup by Route of Administration
    6.5    Market Breakup by Indication
    6.6    Market Breakup by Distribution Channel
    6.7    Market Breakup by Region
    6.8    Market Forecast
    6.9    SWOT Analysis
        6.9.1    Overview
        6.9.2    Strengths
        6.9.3    Weaknesses
        6.9.4    Opportunities
        6.9.5    Threats
    6.10    Value Chain Analysis
    6.11    Porters Five Forces Analysis
        6.11.1    Overview
        6.11.2    Bargaining Power of Buyers
        6.11.3    Bargaining Power of Suppliers
        6.11.4    Degree of Competition
        6.11.5    Threat of New Entrants
        6.11.6    Threat of Substitutes
    6.12    Key Market Drivers and Success Factors
7   Market Breakup by Route of Administration
    7.1    Injectable
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Oral
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Others
        7.3.1    Market Trends
        7.3.2    Market Forecast
8   Market Breakup by Indication
    8.1    Oncology
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Autoimmune Diseases
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Infectious Diseases
        8.3.1    Market Trends
        8.3.2    Market Forecast
    8.4    Others
        8.4.1    Market Trends
        8.4.2    Market Forecast
9   Market Breakup by Distribution Channel
    9.1    Retail Pharmacies
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Specialty Pharmacies
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Hospital Pharmacies
        9.3.1    Market Trends
        9.3.2    Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1    Market Overview
        10.1.2    Market Performance
        10.1.3    Market Breakup by Country
            10.1.3.1    United States
                  10.1.3.1.1    Market Trends
                  10.1.3.1.2    Market Forecast
            10.1.3.2    Canada
                 10.1.3.2.1    Market Trends
                 10.1.3.2.2    Market Forecast
        10.1.4    Market Forecast
   10.2    Europe
        10.2.1    Market Overview
        10.2.2    Market Performance
        10.2.3    Market Breakup by Country
            10.2.3.1    Italy
                   10.2.3.1.1    Market Trends
                   10.2.3.1.2    Market Forecast
            10.2.3.2    Germany
                   10.2.3.2.1    Market Trends
                   10.2.3.2.2    Market Forecast
            10.2.3.3    France
                    10.2.3.3.1    Market Trends
                    10.2.3.3.2    Market Forecast
             10.2.3.4    United Kingdom
                    10.2.3.4.1    Market Trends
                    10.2.3.4.2    Market Forecast
             10.2.3.5    Spain
                   10.2.3.5.1    Market Trends
                   10.2.3.5.2    Market Forecast
        10.2.4    Market Forecast
    10.3    Asia Pacific
        10.3.1    Market Overview
        10.3.2    Market Performance
        10.3.3    Market Breakup by Country
             10.3.3.1    Japan
                  10.3.3.1.1    Market Trends
                  10.3.3.1.2    Market Forecast
             10.3.3.2    China
                 10.3.3.2.1    Market Trends
                 10.3.3.2.2    Market Forecast
             10.3.3.3    India
                 10.3.3.3.1    Market Trends
                 10.3.3.3.2    Market Forecast
             10.3.3.4    South Korea
                 10.3.3.4.1    Market Trends
                 10.3.3.4.2    Market Forecast
        10.3.4    Market Forecast
    10.4    Latin America
        10.4.1    Market Overview
        10.4.2    Market Performance
        10.4.3    Market Breakup by Country
             10.4.3.1    Brazil
                 10.4.3.1.1    Market Trends
                 10.4.3.1.2   Market Forecast
             10.4.3.2    Mexico
                 10.4.3.2.1    Market Trends
                 10.4.3.2.2    Market Forecast
        10.4.4    Market Forecast
    10.5    Middle East and Africa
        10.5.1    Market Overview
        10.5.2    Market Performance
        10.5.3    Market Forecast
11  Competitive Landscape
    11.1    Market Structure
    11.2    Key Players
    11.3    Profiles of Key Players
        11.3.1    Teva Pharmaceuticals Industries
        11.3.2    Akorn, Inc.
        11.3.3    Mylan N.V.
        11.3.4    Mallinckrodt
        11.3.5    Sandoz International GmbH
        11.3.6    Pfizer, Inc.
        11.3.7    Sun Pharmaceutical Industries Ltd.
        11.3.8    Valeant Pharmaceuticals
        11.3.9    Apotex Corp.
        11.3.10    Endo International plc. 

List of Figures

Figure 1: Global: Specialty Generics Market: Major Drivers and Challenges
Figure 2: Global: Specialty Generics Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2023
Figure 4: Global: Specialty Generics Market: Breakup by Indication (in %), 2023
Figure 5: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2023
Figure 6: Global: Specialty Generics Market: Breakup by Region (in %), 2023
Figure 7: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 8: Global: Specialty Generics Industry: SWOT Analysis
Figure 9: Global: Specialty Generics Industry: Value Chain Analysis
Figure 10: Global: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 11: Global: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2018 & 2023
Figure 12: Global: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 13: Global: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2018 & 2023
Figure 14: Global: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 15: Global: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2018 & 2023
Figure 16: Global: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 17: Global: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2018 & 2023
Figure 18: Global: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 19: Global: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2018 & 2023
Figure 20: Global: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 21: Global: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2018 & 2023
Figure 22: Global: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 23: Global: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2018 & 2023
Figure 24: Global: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 25: Global: Specialty Generics Market: Sales Through Retail Pharmacies (in Billion US$), 2018 & 2023
Figure 26: Global: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Billion US$), 2024-2032
Figure 27: Global: Specialty Generics Market: Sales Through Specialty Pharmacies (in Billion US$), 2018 & 2023
Figure 28: Global: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Billion US$), 2024-2032
Figure 29: Global: Specialty Generics Market: Sales Through Hospital Pharmacies (in Billion US$), 2018 & 2023
Figure 30: Global: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Billion US$), 2024-2032
Figure 31: North America: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: North America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: United States: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: United States: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Canada: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Canada: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Europe: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Europe: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Italy: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Germany: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: France: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Spain: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Asia Pacific: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Asia Pacific: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Japan: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Japan: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: China: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: China: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: India: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: India: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: South Korea: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: South Korea: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Latin America: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Latin America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Brazil: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Brazil: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Mexico: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Mexico: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Middle East and Africa: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Middle East and Africa: Specialty Generics Market: Breakup by Country (in %), 2023
Figure 67: Middle East and Africa: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2024-2032
Table 3: Global: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2024-2032
Table 4: Global: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2024-2032
Table 5: Global: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2024-2032
Table 6: North America: Specialty Generics Market: Key Industry Highlights, 2023 and 2032
Table 7: Europe: Specialty Generics Market: Key Industry Highlights, 2023 and 2032
Table 8: Asia Pacific: Specialty Generics Market: Key Industry Highlights, 2023 and 2032
Table 9: Latin America: Specialty Generics Market: Key Industry Highlights, 2023 and 2032
Table 10: Middle East and Africa: Specialty Generics Market: Key Industry Highlights, 2023 and 2032
Table 11: Global: Specialty Generics Market Structure
Table 12: Global: Specialty Generics Market: Key Players

Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distribution channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More